FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
Blood Cancer Patients. The
Connected entities
organizationCellsorganizationDrug AdministrationorganizationFDA Approves New TreatmentorganizationGVHDorganizationPrevent Serious ComplicationsorganizationTregorganizationTREGZI
Appears in 1 topic(s)